Trials / Completed
CompletedNCT00463320
A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.
A Placebo-controlled, Randomized, Dose Rising Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Ocular Doses of Pazopanib in Healthy Adult and Elderly Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 30 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a two-part study to evaluate the safety, tolerability and pharmacokinetics of single (Part A) and repeat (Part B) eye drop doses of pazopanib in healthy adult and elderly subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pazopanib eye drops and Allergen Refresh Plus eye drops |
Timeline
- Start date
- 2007-03-01
- Completion
- 2007-08-01
- First posted
- 2007-04-20
- Last updated
- 2012-03-19
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00463320. Inclusion in this directory is not an endorsement.